Tsingke Unveils ‘Zero-Contact’ Gene Synthesis to Safeguard Core Genetic Sequences
As the pace of biotechnology research accelerates, companies are increasingly [...]
Variational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discovery
Variational AI introduces Enki 4: an improved algorithm and architecture [...]
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Akira Kitamura, GM, AI Drug Development Division of NEC Corporation [...]
iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite [...]
Miniature laser technology could bring lab testing into your home
By studying how various biomolecules interact with each other – [...]
Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development
Each partner company has opted in to share operational data [...]
Cenevo Advances Toward Agentic Labs with Two New AI Agents
The new agents are the AI Protocol Conversion agent and [...]
Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease
Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory [...]
TheWell Bioscience Reports the Launch of VitroPrime™ 3D Culture and Imaging Plate for Organoid and 3D Cell Culture Workflows
Through a unique combination of sample-locking architecture, passive media exchange, [...]
Massive Bio Launches TrialRelay™ at SCOPE 2026: An Operating System to End “Referral Black Holes” in Oncology
Massive Bio introduces TrialRelay, a physician-facing operating system designed to [...]